Cash and Cash Equivalents, at Carrying Value of DMK PHARMACEUTICALS Corp from 31 Mar 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
DMK PHARMACEUTICALS Corp quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Mar 2010 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2023 was $6,663,921, a 175% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

DMK PHARMACEUTICALS Corp Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $6,663,921 +$4,243,961 +175% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $640,254 -$8,235,671 -93% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 $3,099,843 -$14,667,892 -83% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,081,364 -$22,139,406 -95% 31 Dec 2022 10-Q 14 Nov 2023 2023 Q3
Q3 2022 $2,419,960 -$26,311,934 -92% 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $8,875,925 -$31,429,513 -78% 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 $17,767,735 -$39,862,894 -69% 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $23,220,770 +$16,471,825 +244% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $28,731,894 +$16,689,277 +139% 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $40,305,438 +$32,414,235 +411% 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $57,630,629 +$47,124,608 +449% 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $6,748,945 -$2,061,691 -23% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $12,042,617 -$79,297 -0.65% 30 Sep 2020 10-Q 22 Nov 2021 2021 Q3
Q2 2020 $7,891,203 +$3,798,514 +93% 30 Jun 2020 10-Q 22 Nov 2021 2021 Q2
Q1 2020 $10,506,021 +$1,315,944 +14% 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 $8,810,636 -$10,461,006 -54% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 $12,121,914 -$19,912,670 -62% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $4,092,689 +$686,358 +20% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $9,190,077 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $19,271,642 +$1,948,401 +11% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $32,034,584 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $3,406,331 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q4 2017 $17,323,241 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q2 2014 $2,129,613 30 Jun 2014 10-Q 13 Aug 2014 2014 Q1
Q1 2014 $5,403,235 31 Mar 2014 10-Q 13 Aug 2014 2014 Q1
Q4 2013 $4,674,162 +$4,672,739 31 Dec 2013 10-Q 14 Feb 2014 2013 Q3
Q3 2013 $119,579 +$109,490 +1085% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q2
Q4 2012 $1,423* -$179 31 Dec 2012 10-Q 19 Feb 2013 2012 Q3
Q3 2012 $10,089 +$7,063 30 Sep 2012 10-Q 13 Nov 2012 2012 Q2
Q2 2012 $720,042 +$528,819 +277% 30 Jun 2012 10-Q/A 17 Aug 2012 2012 Q1
Q1 2012 $7,519* -$1,231,379 31 Mar 2012 10-Q 19 Feb 2013 2012 Q3
Q4 2011 $1,602* -$2,562,994 31 Dec 2011 10-Q 14 Feb 2012 2011 Q3
Q3 2011 $3,026* -$94,611 30 Sep 2011 10-Q 13 Nov 2012 2012 Q2
Q2 2011 $191,223 -$55,146 -22% 30 Jun 2011 10-Q/A 17 Aug 2012 2012 Q1
Q1 2011 $1,238,898 +$948,599 +327% 31 Mar 2011 10-Q 13 Nov 2012 2012 Q2
Q4 2010 $2,564,596 31 Dec 2010 10-Q 14 Feb 2012 2011 Q3
Q3 2010 $97,637 30 Sep 2010 10-Q 21 Nov 2011 2011 Q2
Q2 2010 $246,369 30 Jun 2010 10-Q 15 Aug 2011 2011 Q1
Q1 2010 $290,299 31 Mar 2010 10-K 29 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.